The 61st ASH Annual Meeting: Unwrapping the Best From Hematology's Christmas
2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition which took place early December in Orlando.
Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid
Dr. Tseng discusses several studies that investigate the efficacy and safety of tranexamic acid in patients with traumatic brain injury.
Dr. Maese and Dr. Raetz review several studies that have defined the scope and magnitude of medication nonadherence in childhood ALL including the fact that one-third of ALL relapses are attributed to 6-MP nonadherence. They stress the need for simplification of 6-MP delivery instructions.
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Dr. Raetz looks at a study that shows response-based therapy in both children and adults with ETP-ALL is effective.
Dr. Raetz discusses a report that provides important new insight into improving the accuracy of induction response assessment by incorporating MRD.
Dr. Raetz looks at a report that shows that Ph-like ALL is common across the age spectrum.
Drs. Raetz and Kovacsovics cover a trial meant to develop a precision medicine approach for the treatment of AML.
Dr. Raetz reviews changes that have emerged in 2016 in the treatment of acute lymphocytic leukemia for both children and adults.
Dr. Raetz looks at a highly promising new monoclonal antibody therapy for CD22-positive B-cell acute lymphoblastic leukemia.
Dr. Raetz looks at the possibility of therapy reduction in carefully defined good risk subsets due to improvements in acute lymphoblastic leukemia outcomes.
Dr. Raetz compares dexamethasone and prednisone for the induction phase of treatment of childhood acute lymphocytic leukemia.
January-February 2020Volume 17, Issue 1
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology